Great science shouldn't go unnoticed — or unfunded.
Clario Biotech turns dense, technical research into a strategic narrative that gets investors to act and lets the public understand what they're funding.
Most science communication agencies reword what a researcher says. They don't synthesize the research closely enough to build a narrative that moves a funding decision, earns real attention, or makes the public care. When science stays locked in technical language, it doesn't just confuse people — it loses the visibility that funding depends on.
"...ideal partner for early-stage founders who need to move from technical data to a clear, credible story."Featured in PeekWire Top 5 biotech communication agencies, 2026 →
The 3 C's
Core Insights from Complete Research
Not surface-level summaries. Strategic narratives built from a full read of your science.
Consistency Across All Documents
One agency, one strategic direction — not a patchwork of freelancers producing inconsistent style.
Custom Work for Your Use Case
No templates. Every deliverable is shaped around your specific research, audience, and funding stage.
Built for early-stage biotech founders and research teams preparing to raise, partner, or be understood by the people outside their lab who decide what gets funded and what gets noticed.
Ready to see how it works?
See exactly what Clario builds from a single research paper on the Portfolio page, or skip straight to a conversation.